Session Time: 1:45pm-3:15pm
Location: Hall 3FG
Objective: We evaluated the screening ability of the Korean version of the Montreal Cognitive Assessment (K-MoCA) in the patients with Parkinson’s disease.
Background: The Montreal Cognitive Assessment (MoCA) is a brief cognitive screening tool with high sensitivity for screening paitents with early cognitive dysfunction.
Methods: We examined 458 consecutive participants with Parkinson’s disease (1 16 control, 250 with MCI, and 92 with dementia).Receiver operating characteristic (ROC) curves determined dichotomous classification parameters. Multi-category ROC surfaces were evaluated to classify three stages of cognitive dysfunction.
Results: Simultaneous multi-category classification analyses showed that the volume under the ROC surface was 0.63 and the derived optimal cut-off points were 5 and 14 for control, MCI, and dementia in patients with Parkinson’s disease.
Conclusions: This study showed that the K-MoCA is brief, reliable, and suitable for use as a screening tool to screen cognitive dysfunction in patients with Parkinson’s disease.
To cite this abstract in AMA style:M. Park, D. Kwon. Brief Cognitive Screening for Parkinson’s disease by the Korean Version of the Montreal Cognitive Assessment [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/brief-cognitive-screening-for-parkinsons-disease-by-the-korean-version-of-the-montreal-cognitive-assessment/. Accessed December 5, 2023.
« Back to 2018 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/brief-cognitive-screening-for-parkinsons-disease-by-the-korean-version-of-the-montreal-cognitive-assessment/